Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | OAT | P04181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14439278 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL21757620 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL799755 | 1.00 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL29550605 | 0.83 | GABRR1 (0.42) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL20363529 | 0.82 | GABRR1 (0.33) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL416062 | 0.82 | GABRR1 (0.33) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL17453292 | 0.79 | GABRR1 (0.32) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL419019 | 0.70 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL12929618 | 0.70 | GABRR1 (0.36) | GABRR1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL19215291 | 0.68 | NOS3 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 731 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260097105-A1 | SYSTEMS, FORMULATIONS AND METHODS FOR GENERATING UNIVERSAL PEPTIDE/MHC COMPLEXES WITH ENGINEERED DISULFIDE CONNECTING THE HEAVY AND LIGHT CHAINS | CHILDRENS HOSPITAL PHILADELPHIA (US) | 2026-04-09 | — | — | US | claimed |
| EP-4720317-A1 | BIOLOGICAL ANISOLE PRODUCTION | Wageningen Universiteit (NL) | 2026-04-08 | — | — | EP | claimed |
| EP-4687989-A1 | PROTEIN TYROSINE PHOSPHATASE WEDGE DOMAIN PEPTIDE DIMER FOR NERVOUS SYSTEM REPAIR | Nervgen Pharma Corp. (CA) | 2026-02-11 | — | — | EP | claimed |
| EP-4617282-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | Institute Of Pathogen Biology, Chinese Academy Of Medical Sciences (CN) | 2025-09-17 | — | — | EP | claimed |
| CN-119372167-A | Escherichia coli-derived shikimate dehydrogenase mutant and method for producing shikimate | 福建师范大学 | 2025-01-28 | — | — | CN | claimed |
| US-20250019728-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND | KAO CORPORATION (JP) | 2025-01-16 | — | — | US | claimed |
| CN-119242722-A | Method for preparing shikimic acid or improving shikimic acid yield | 福建师范大学 | 2025-01-03 | — | — | CN | claimed |
| CN-119193446-A | Recombinant strain for producing 3-dehydroshikimic acid escherichia coli, construction method and application | 山东阳成协盈生物技术有限责任公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119177201-A | Recombinant engineering bacterium for producing aromatic amino acid and construction method and application thereof | 中国科学院天津工业生物技术研究所 | 2024-12-24 | — | — | CN | claimed |
| WO-2024253523-A1 | BIOLOGICAL ANISOLE PRODUCTION | WAGENINGEN UNIVERSITEIT (NL) | 2024-12-12 | — | — | WO | claimed |
| US-20060241078-A1 | Pharmaceutical compositions comprising a contraceptive agent in solution and a teratogen | AHMED SALAH U | 2006-10-26 | — | — | US | claimed |
| WO-2006023496-A2 | VAGINAL CREAM COMPOSITIONS, KITS THEREOF AND METHODS OF USING THEREOF | DURAMED PHARMACEUTICALS, INC. (US) | 2006-03-02 | — | — | WO | claimed |
| US-20060040904-A1 | Vaginal cream compositions, kits thereof and methods of using thereof | DURAMED PHARMACEUTICALS, INC. | 2006-02-23 | — | — | US | claimed |
| US-6472190-B1 | CULTURING A HOST CELL CAPABLE OF CONVERTING THE CARBON SOURCE TO 3-DEHYDROSHIKIMIC ACID AND A RECOMBINANT DNA ENCODING AN ENZYME WHICH CONVERTS 3-DEHYDROSHIKIMIC ACID TO PROTOCATECHUIC ACID, AN ENZYME WHICH CONVERTS IT TO GALLIC ACID | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERISITY | 2002-10-29 | — | — | US | claimed |
| EP-0934062-B1 | ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES | UNIV MICHIGAN STATE (US) | 2002-03-27 | — | — | EP | claimed |
| WO-2001071020-A2 | BIOCATALYTIC SYNTHESIS OF GALLOID ORGANICS | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2001-09-27 | — | — | WO | claimed |
| EP-0934062-A4 | ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES | UNIV MICHIGAN STATE (US) | 2000-06-07 | — | — | EP | claimed |
| EP-0934062-A1 | ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES | MICHIGAN STATE UNIVERSITY (US) | 1999-08-11 | — | — | EP | claimed |
| US-5821266-A | Antioxidant activity of 3-dehydroshinkimates | MICHIGAN STATE UNIVERSITY (US) | 1998-10-13 | — | — | US | claimed |
| WO-1998003169-A1 | ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES | MICHIGAN STATE UNIVERSITY (US) | 1998-01-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097105-A1 | SYSTEMS, FORMULATIONS AND METHODS FOR GENERATING UNIVERSAL PEPTIDE/MHC COMPLEXES WITH ENGINEERED DISULFIDE CONNECTING THE HEAVY AND LIGHT CHAINS | HLA-DRB1, MICA, FTH1 | GABRR1 3545/4885TSHR 1149/4885MAPK1 1748/4885 |
| US-20060241078-A1 | Pharmaceutical compositions comprising a contraceptive agent in solution and a teratogen | CYP19A1, CYP21A2, CYP17A1 | GABRR1 946/4885TSHR 1339/4885MAPK1 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.